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It has been known that osteoclastogenesis is induced by extracellular acidosis-evoked the rise of
intracellular calcium ([Ca2+]i), which regulate activation of the transcription factor nuclear factor
of activated T cells c1 (NFATc1). However, the acid-sensing ion channels (ASICs) involved remain lar-
gely unknown. Here, we show that ASIC1a, ASIC1b, ASIC2a, and ASIC3 are expressed in rat osteo-
clasts, and only ASIC1a is highly upregulated in response to acidosis. Both the ASIC1a-speciﬁc
blocker PcTX1 and speciﬁc siRNA signiﬁcantly reduce this increase in acid-induced [Ca2+]i and
acid-induced nuclear translocation of NFATc1, and inhibit acid-induced osteoclast differentiation
and bone resorption. These ﬁndings show that ASIC1a-mediated calcium entry plays a critical role
in osteoclastogenesis by regulating activation of the NFATc1.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bone homeostasis is strictly regulated by control of both bone
resorption by osteoclasts and bone formation by osteoblasts [1].
Most adult skeletal diseases, such as osteoporosis and Paget’s dis-
ease, are mostly or partially due to excess osteoclastic activity [2].
Osteoclasts are bone-resorbing cells that are specialized to break
down and absorb bone tissue [3]. At present it is widely believed
that two key regulators produced by bone marrow mesenchymal
cells are essential for osteoclastogenesis: macrophage colony-stim-
ulating factor (M-CSF) and receptor activator of nuclear factor kap-
pa B (NF-jB) ligand (RANKL) [4]. In addition to M-CSF and RANKL,
Recent studies have demonstrated that extracellular acidosis is a
potent modulator of the resorptive activity of mature osteoclasts
[5]. Further study found that extracellular acidiﬁcation enhances
osteoclast differentiation by regulating the acid-induced rise in
[Ca2+]i [6]. Although many acid-sensitive proteins such as ovarian
cancer G protein-coupled receptor 1 (OGR1) and transient receptor
potential (TRP) vanilloid-1 (TRPV1) ion channels involved in the
activation of osteoclasts in extracellular acidosis have been identi-
ﬁed [7–9], many more components are yet to be discovered.
ASICs, a novel class of ligand-gated cation channels, belong to
the degenerin/epithelial Na+ channel (DEG/ENaC) superfamily [8].They are activated by a fall in the extracellular pH and are cat-
ion-selective. Recently, many studies have demonstrated that
ASICs are expressed not only in nervous system but also in non-
neuronal cells such as dendritic cells, chondrocytes, osteoblasts,
osteoclasts, nucleus pulposus cells, carotid body glomus cells,
and synoviocytes, suggesting more diverse roles for ASICs in phys-
iological and pathogenic processes [10,11]. To date, at least six sub-
units of ASICs have been identiﬁed: 1a, 1b, 2a, 2b, 3 and 4. Of these,
ASIC1a is the subunit that is reported to be permeable to Ca2+, as it
differs from other ASIC subunits [12]. Recent studies have
indicated that ASIC1a is involved in synaptic plasticity, learning,
memory, articular chondrocyte injury, and ischemic brain injury
[13,14].
The increase in [Ca2+]i signaling is a critical regulator of osteo-
clastogenesis, by inducing nuclear factor of activated T cells c1
(NFATc1)-dependent gene transcription, the master regulator of
osteoclastogenesis [15]. However, the way in which the [Ca2+]i in-
crease is regulated during osteoclastogenesis in extracellular aci-
dosis remains largely unknown. Previous work has shown that
ASICs are expressed at high levels in bone cells [16]. However it
is uncertain whether ASIC1a is expressed in rat osteoclasts, and
whether it directly mediates Ca2+ inﬂux and increased [Ca2+]i in
extracellular acidosis. It is also uncertain whether ASIC1a contrib-
utes to osteoclastogenesis through an acidosis-evoked increase in
[Ca2+]i. Therefore, the aim of our current study was to establish
the expression of ASIC1a genes in osteoclasts and identify their role
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NFATc1 signaling pathways.2. Materials and methods
2.1. Isolation of osteoclasts
Bone marrow-derived macrophages (BMMs) were obtained as
osteoclast precursors using the following procedures. BMMs were
prepared by ﬂushing out the bone marrow cavity of rats using a-
MEM, which was supplemented with 10% fetal calf serum contain-
ing 30 ng/ml M-CSF. The non-adherent cells were collected after
24 h and used as osteoclast precursors. Cells were seeded at a den-
sity of 1  106 cells/well in the presence of RANKL (50 ng/ml) and
M-CSF (30 ng/ml) for 5–6 days. The culture medium was replaced
every 3 days. Samples were then stained for TRAP using the Leuko-
cyte Acid Phosphatase Staining Kit (Sigma–Aldrich, St Louis, MO)
according to the manufacturer’s instructions. Multinuclear cells
containing three or more nuclei that stained positive for TRAP were
counted by light microscopy. TRAP-positive multinucleated cells
containing three or more nuclei were considered to be osteoclasts.
2.2. Real-time PCR and RT-PCR analysis
Total RNA was extracted with TRIzol reagent (Invitrogen)
according to the manufacturer’s instructions. Real-time PCR was
performed using 0.1 ll of cDNA with SYBR Green dye detection
of ampliﬁcation products (Applied Biosystems, Foster City, CA) on
a GeneAmp 5700 Sequence Detection System. To prepare culture
media of different extracellular pH values, including pH 6.0, 6.5,
7.0, and 7.5, the pH buffering of cell culture medium was carried
out as previously described [17]. In all acid-induced experiments,
blockers of voltage-gated Ca2+ channels (5 lM nimodipine and
3 lM x-conotoxin MVIIC), glutamate receptors (10 lM MK-801),
TRPV1 (2 lM capsazepine), and OGR1 (100 lM, CuCl2) were added
to extracellular solutions to inhibit possible secondary activation of
these channels. Gene expression levels were normalized to GAPDH
and were calculated using the DDCt method. The primers used are
listed in Table S1. The RT-PCR product of ASIC1a was electrophore-
sed on 1.2% agarose gels and stained with ethidium bromide.
2.3. Western blot
Whole cells were lysed in lysis buffer, supplemented with pro-
tease inhibitor mixture (Roche Applied Science, Indianapolis, IN).
Protein concentration was determined for each sample using the
BCA-200 Protein Assay Kit (Pierce, Rockford, IL). The lysates were
resolved by denaturing 12% SDS–PAGE and transferred to Immobi-
lon polyvinyldiﬂuoride membranes. The membranes were probed
with primary antibody against ASIC1a (Alpha Diagnostic Interna-
tional, San Antonio, TX) and NFATc1 (Santa Cruz Biotechnology,
Santa Cruz, CA) for 1 h. After three washes, the blots were subse-
quently incubated with a secondary antibody for 1 h. The blots
were developed using the Western Blue stabilized substrate for
alkaline phosphatase.2.4. Immunoﬂuorescent cell staining
Cells were permeabilized with 0.1% Triton X-100 in phosphate
buffered saline (PBS), and then the cells were washed in PBS con-
taining 5% FBS and labeled with primary anti-ASIC1a antibody for
2 h. After washing with PBS, the primary antibody was detected
with Texas red conjugated secondary antibodies (Molecular
Probes).For NFATc1 immunostaining, osteoclasts were switched to dif-
ferent pH levels for 1 h or mixed with the ASIC1a-speciﬁc blocker,
PcTX1 (100 ng/ml, Alomone Labs, Ltd., Jerusalem, Israel). Cells were
then washed with PBS and incubated with an anti-NFATc1 anti-
body. After washing, the cells were incubated with Alexa Fluor-
488-conjugated secondary antibody (Molecular Probes). Cells were
washed again with PBS and stained with DAPI (Sigma–Aldrich) for
15 min to identify multinucleated cells. Cells were washed and im-
aged using a laser scanning confocal microscope.
2.5. Fluorescence imaging of [Ca2+]i
[Ca2+]i of isolated rat osteoclasts was monitored using ﬂuores-
cence imaging [6]. Cells on glass coverslips were washed three
times with D-Hanks’ solutions and incubated with 4 lM fura-2
and 0.02% acetoxymethyl (Biotium, Hayward, CA) for 40 min, fol-
lowed by three washes and additional incubation in normal Hanks’
solutions for 30 min. Coverslips were washed and placed in a
chamber mounted on the stage of an inverted microscope (Nikon)
and superfused at room temperature with extracellular solution
containing, which contained in mM: NaCl, 140; KCl, 5.4; glucose,
15; MgCl2, 1; CaCl2, 1.3; HEPES, 20; pH 7.5 using NaOH. Fura-2
was excited at 340 and 380 nm, and emission was measured at
510 nm. Digitized images were analyzed on a computer controlled
by Leica-sp5 LAS AF software. Images (340:380 ratio) were ana-
lyzed by averaging pixel ratio values in circumscribed regions of
cells in the ﬁeld of view. The values were exported from Axon
Imaging Workbench software to SigmaPlot for additional analysis
and plotting.
2.6. siRNA transfection
The cDNA sequence of rat ASIC1a was obtained from GenBank
(U94403). To stably knock down ASIC1a expression, we used lenti-
virus packing siRNA expression vector (synthesized by GenePhar-
ma, Shanghai, China) to infect cells. A negative control RNAi (NC-
RNAi) was purchased from Genepharma. Target osteoclasts were
infected with lentivirus for 24–48 h according to manufacturer’s
instruction. The RNAi oligonucleotides sequence used to knock
down ASIC1a expression is in Table S2.
2.7. Osteoclast differentiation and resorption assays
Osteoclast differentiation and resorption were measured as de-
scribed previously [6]. The cells were seeded into tissue culture
dishes, and large multinucleated cells were counted in a standard
central area (3.14 cm2) using phase-contrast microscopy. The cells
were then treated by incubation in different acid pH values for 18 h
in a-MEM. Osteoclasts were then ﬁxed in 4% paraformaldehyde,
washed twice with PBS, and stained with TRAP to distinguish
osteoclasts. To measure resorption, osteoclasts were cultured and
treated as described above. The cells were scraped, counted, and
re-plated onto dentine slices at 1  104 cells/well. Osteoclasts were
incubated with different acid pH values for 18 h, then removed by
sonication and the dentine was stained with toluidine blue to iden-
tify resorption pits. The resorption area was quantiﬁed with ImageJ
software.
2.8. Statistical analyses
Data were expressed as the mean ± standard error of the mean.
Statistical analysis was performed with one-way analysis of vari-
ance (ANOVA) followed by a least signiﬁcant difference (LSD) post
hoc test and the Student’s t-test. P < 0.05 was considered
signiﬁcant.
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3.1. ASICs are expressed in osteoclasts
To examine whether ASICs are involved in acid-induced osteo-
clast differentiation in rat bone marrow cells, we ﬁrst measured
the mRNA levels of ASICs in response to acidosis. BMMs were stim-
ulated for 5 days with 50 ng/ml RANKL and 30 ng/ml M-CSF. Then
the cells were stimulated at pH 6.0, 6.5, 7.0, and 7.5 for 18 h. Total
cellular RNA was extracted from the induced cells and used for
real-time RT-PCR. This analysis revealed that ASIC1a mRNA expres-
sion was highly upregulated in response to acidosis in rat osteo-
clasts, whereas the expression of other ASIC subtypes including
ASIC1b, ASIC2a, and ASIC3 was unchanged in response to acidosis,
however, no expression of either ASIC2b or ASIC4 was detected in
rat osteoclasts (Fig. 1A). As shown in Fig. 1A, the expression of ASI-
C1a mRNA in response to acidosis was pH dependent, and the max-
imum response appeared at pH 6.0. This indicates that ASIC1a is
pH responsive in rat osteoclasts (Fig. 1A).
We next examined the expression of mRNA encoding ASIC1a in
osteoclasts. RT-PCR analysis showed clear expression of ASIC1a in
rat osteoclasts (Fig. 1B), which was consistent with data from a po-
sitive control. Western blot analysis revealed that ASIC1a protein
(approximately 80 kDa) was expressed at readily detectable levels
in rat osteoclasts (Fig. 1C). To study the subcellular localization of
ASIC1a by immunoﬂuorescence, osteoclasts were ﬁxed and co-
stained for ASIC1a and indicated markers. As depicted in Fig. 1D,
ASIC1a was found in dot-like structures dispersed throughout the
cytoplasm, while an intense signal on the plasma membrane was
also evident. Negative controls without anti-ASIC1a gave no signal
(Fig. 1E). These data indicate the presence of ASIC1a in rat osteo-
clasts, providing a means to sense and respond to differences in
extracellular pH.Fig. 1. Detection of ASICs in rat osteoclasts. (A) Real-time RT-PCR analysis of ASIC
expression in osteoclasts incubated at different pH values for 18 h. Data were
normalized to levels of b-actin. ⁄⁄P < 0.01 compared with pH 7.5. (B) RT-PCR
analysis of mRNA isolated from cultured osteoclasts revealed the presence of mRNA
for ASIC1a. (C) Western blot of ASIC1a protein from cultured osteoclasts. A speciﬁc
signal was detected at a molecular mass of approximately 80 kDa in the cultured rat
osteoclasts, which corresponded to the expected molecular weight of recombinant
ASIC1a protein. (D) Subcellular localization of ASIC1a protein in osteoclasts. A
speciﬁc signal was detected in the the cytoplasm and plasma membrane of most
osteoclasts (red). Nuclei were stained with DAPI (blue). Immunoﬂuorescent double
staining was observed in treated osteoclasts, and showed only nuclear staining. (E)
No positive staining was observed in osteoclasts when non-immune IgG was used.
Bar is 25 lm.3.2. Increased [Ca2+]i induced by acidic stimulation via ASIC1a in
osteoclasts
Previous studies reported that acidosis also leads to the rise of
[Ca2+]i in osteoclasts [7]. Using Ca2+-imaging experiments, we
determined whether ASIC1a in osteoclasts is Ca2+ permeable. From
the Ca2+-imaging (Fig. 2A), the application of extracellular acid (pH
6.0) caused transient rise of [Ca2+]i in osteoclasts (Fig. 2A and E). As
an additional test of the involvement of ASIC1a, we applied the
PcTX1 (100 ng/ml) and found that this response was diminished
(Fig. 2B and E). To directly examine the involvement of ASIC1a in
acid-induced changes in [Ca2+]i, we knocked down the expression
of ASIC1a using siRNA in BMMs. We made three ASIC1a siRNA con-
structs and found that siRNA#3 can effectively lower the cellular
level of ASIC1a (Fig. S1A and 1B). Strikingly, knock-down of ASIC1a
expression suppressed the acid-induced rise of Ca2+ in osteoclasts
derived from BMMs (Fig. 2C and E). However, we did not observe
any changes in NC-RNAi group (Fig. 2D and E). These data conﬁrm
an essential role for ASIC1a in mediating acid-induced [Ca2+]i in
osteoclasts.3.3. Acid-induced [Ca2+]i increase via ASIC1a is responsible for
osteoclastogenesis
It has been established that the acid-induced rise of [Ca2+]i con-
tributes to regulation of osteoclast differentiation [6]. To determine
whether Ca2+ entry plays a role in acid-induced osteoclastogenesis,
we treated cells with extracellular solution at pH 6.0, 6.5, 7.0 and
7.5 for 18 h (Fig. 3A). As shown in Fig. 3A and B, acidic pH-induced
osteoclast differentiation was estimated using TRAP staining at
18 h. A signiﬁcant increase was detected at pH 6.0, 6.5, 7.0, andincreasing extracellular acidiﬁcation resulted in a dose-dependent
increase in the osteoclast differentiation compare to control at pH
7.5 (Fig. 2B). To determine whether activation of ASIC1a is involved
in acid-induced osteoclast differentiation, we tested the effect of
PcTX1 and ASIC1a-speciﬁc RNAi, but not NC-RNAi, on osteoclast
differentiation. As shown in Fig. 3B and C, the effect of acid incuba-
tion for 18 h on osteoclast differentiation was reduced by 100 ng/
ml PcTX1 and by ASIC1a-speciﬁc RNAi.
It has been shown that the calcineurin inhibitor cyclosporine A
and the Ca2+ chelator BAPTA potently suppress the RANKL-induced
differentiation of osteoclasts through inhibition of NFATc1 nuclear
translocation, suggesting that activation of the calcium–NFATc1 sig-
naling pathway is crucial for osteoclast differentiation [18]. Thus,
we next examined whether acid-induced [Ca2+]i elevation via acti-
Fig. 2. Acid-induced elevation of [Ca2+]i level. (A) Acid-induced elevation of [Ca2+]i in the cultured rat osteoclasts. (B) Acid-induced elevation of [Ca2+]i in the cultured rat
osteoclasts treated with PcTX1. (C) Acid-induced elevation of [Ca2+]i in the cultured rat osteoclasts treated with ASIC1a-speciﬁc RNAi. (D) Acid-induced elevation of [Ca2+]i in
the cultured rat osteoclasts treated with NC-RNAi. (E) The amplitude of [Ca2+]i intensity in osteoclasts induced by acid treatment was quantiﬁed as the maximal rise of [Ca2+]i
above basal levels. ##P < 0.01 compared with control (pH 7.5); ⁄⁄P < 0.01 compared with pH 6.0.
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using the intracellular Ca2+ chelator BAPTA. Similar to the effects
of the PcTX1 and ASIC1a-speciﬁc RNAi, enhancement of osteoclast
differentiation at pH 6.0 was abolished by chelation of cytosolic
Ca2+ with BAPTA (50 lM), but BAPTA did not affect differentiation
of osteoclasts cultured at pH 7.5 (Fig. 3D). In summary, these results
indicate that the acid-induced increase of [Ca2+]i mediated by ASI-
C1a is responsible for osteoclastogenesis. To evaluate the role of
the calcineurin/NFATc1 pathway inmediating the effects of acidosis
on differentiation, we investigated the effect of cyclosporine A
(1 mg/ml), a speciﬁc calcineurin inhibitor, on acid-induced osteo-
clast differentiation. As shown in Fig. 3E, cyclosporine A inhibited
acid-induced osteoclast differentiation. Similar to BAPTA, cyclo-
sporine A inhibited acid-induced osteoclast differentiation
(Fig. 3E). Consistent with the osteoclast differentiation results,
administration of PcTX1 andASIC1a-speciﬁc RNAi, but notNC-RNAi,
reduced acid-induced osteoclastic bone resorption (Fig. 3F and G).
3.4. ASIC1a is involved in acid-stimulated NFATc1 signaling in
osteoclastogenesis
NFATc1 in the nucleus is activated by Ca2+ signaling, which ex-
plains why activation of the Ca2+–NFATc1 pathway is crucial for
osteoclast differentiation [15,19]. Moreover, the Ca2+–calmodulin
pathway also induces c-fos expression after c-fos binding to c-
jun increases NFATc1 transcription [15].To gain insight into the mechanism by which the ASIC1a–Ca2+–
NFATc1 axis positively regulates osteoclast differentiation via the
activation of NFATc1, we treated osteoclasts in the presence of
extracellular solution at pH 6.0 or 7.5 for 18 h, and extracted
RNA from cultured cells for real-time RT-PCR analysis. As shown
in Fig. 4A, we conﬁrmed that mRNA levels of NFATc1 in rat osteo-
clasts were substantially up-regulated after treatment with extra-
cellular solution at pH 6.0 compared with extracellular solution at
pH 7.5 (Fig. 4A). In particular, the up-regulation of NFATc1 induced
by pH 6.0 was signiﬁcantly attenuated in osteoclasts treated with
PcTX1 and ASIC1a-speciﬁc RNAi, but not NC-RNAi (Fig. 4A).
Although it is well known that the Ca2+–calmodulin pathway also
induces c-fos expression after c-fos binding to c-jun increases
NFATc1 transcription, we did not detect any changes of c-fos or
c-jun mRNA expression in osteoclasts treated with PcTX1 and ASI-
C1a-speciﬁc RNAi (Fig. S2).
Next we carried out western blot analyses to investigate
whether inhibition of ASIC1a also affects production of NFATc1
protein in acid-mediated NFATc1 signaling in osteoclast differenti-
ation. Whole cell fractions were prepared from osteoclasts treated
with PcTX1, ASIC1a-speciﬁc RNAi, and NC-RNAi cultured with or
without extracellular solution at pH 6.0. As shown in Fig. 4B,
NFATc1 protein was signiﬁcantly up-regulated in response to pH
6.0 treatment compared with controls cultured in extracellular
solution at pH 7.5. Moreover, we found that extracellular acidosis
induction of NFATc1 protein was reduced in lysates prepared from
Fig. 3. Acid-induced [Ca2+]i increase via ASIC1a is involved in acid-induced osteoclastogenesis. (A) Acidosis-induced osteoclast differentiation. BMMs were differentiated into
osteoclasts in 96-well culture plates, and then osteoclasts were incubated at different pH values for 18 h. After TRAP staining, TRAP+ multinuclear cells (TRAP+ MNCs) with
more than three nuclei were scored as osteoclasts. ⁄P < 0.05 compared with control (pH 7.5); ⁄⁄P < 0.01 compared with control (pH 7.5). (B) Osteoclast differentiation was
determined by counting of TRAP-positive cells with more than three nuclei, which were counted as viable osteoclasts. (C) Acid-induced cell differentiation in an extracellular
solution treated with PcTX1 and ASIC1a-speciﬁc RNAi. ##P < 0.01 compared with control (pH 7.5); ⁄P < 0.05 compared with pH 6.0; ⁄⁄P < 0.01 compared with pH 6.0. (D)
Chelation of cytosolic Ca2+ with BAPTA inhibited the effect of extracellular solution at pH 6.0 on osteoclast differentiation, but did not affect osteoclast differentiation at pH
7.5. ⁄⁄P < 0.01 compared with pH 6.0. (E) Inhibition of calcineurin with cyclosporine A decreased osteoclast differentiation at pH 6.0, but did not affect differentiation at pH
7.5. ⁄⁄P < 0.01 compared with pH 6.0. (F) Bone resorption lacuna stained with toluidine blue. Bar is 50 lm. (G) Quantiﬁcation of resorption, total area of resorption. ##P < 0.01
compared with control (pH 7.5); ⁄P < 0.05 compared with pH 6.0; ⁄⁄P < 0.01 compared with pH 6.0.
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RNAi (Fig. 4B).
To determine whether ASIC1a is involved in acid-stimulated
NFATc1 activity, we investigated the localization of NFATc1 after
acid stimulation following pretreatment with PcTX1, ASIC1a-spe-
ciﬁc RNAi, and NC-RNAi, which is used extensively in evaluating
NFATc1 activity in osteoclasts. As shown in Fig. 4C, the majority
of NFATc1 was located in the cytoplasm, maintained at pH 7.5.
Upon stimulation by extracellular acidiﬁcation (pH 6.0), nuclear
translocation in cells signiﬁcantly was increased. Interestingly,
acid-induced NFATc1 nuclear translocation was blocked by PcTX1and ASIC1a-speciﬁc RNAi. However, the majority of NFATc1 was lo-
cated in the cytoplasm in NC-RNAi group (date not shown).
Previous reports have shown that NFATc1 regulates osteoclastic
genes such as TRAP, cathepsin K, and osteoclast-associated recep-
tor (OSCAR), which are known to be involved in osteoclast differen-
tiation [20]. Thus, we next used real-time RT-PCR to investigate the
regulation of these key genes downstream of NFATc1 in osteoclasts
treated with PcTX1, ASIC1a-speciﬁc RNAi, and NC-RNAi. We found
that all three genes are highly up-regulated in response to pH 6.0
(Fig. 4D). However, consistent with the decrease in NFATc1 expres-
sion, induction of TRAP, cathepsin K, and OSCAR by pH 6.0 was
Fig. 4. ASIC1a is involved in acid-stimulated NFATc1 signaling in osteoclastogenesis. (A) Osteoclasts were cultured in an extracellular solution at pH 6.0 for 18 h, and real-
time RT-PCR analysis of NFATc1 message level was performed. (B) NFATc1 protein levels were determined by Western blot (upper panel). Molecular mass markers (kDa) are
as indicated. Arrows indicate three NFATc1 isoforms. Densitometry of the NFATc1 protein bands (lower panel). ##P < 0.01 compared with control (pH 7.5); ⁄⁄P < 0.01
compared with pH 6.0. (C) NFATc1 localization was assessed by immunoﬂuorescence and nuclei were stained with DAPI. In extracellular solutions at pH 7.5, NFATc1 showed
predominantly cytoplasmic localization. Extracellular acidiﬁcation to pH 6.0 induced nuclear accumulation of NFATc1. Images of osteoclasts plated on PcTX1 and ASIC1a-
speciﬁc RNAi at pH 6.0 showing NFATc1 localized predominantly in the cytoplasm. Bar is 25 lm. (D) Real-time RT-PCR analysis of expression of the osteoclastic genes TRAP,
cathepsin K, and OSCAR, known to be direct transcriptional s of NFATc1 in osteoclast differentiation. ##P < 0.01 compared with control (pH 7.5); ⁄⁄P < 0.01 compared with pH
6.0.
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RNAi, but not NC-RNAi (Fig. 4D). These ﬁndings suggest that ASI-
C1a-mediated Ca2+ entry contributes signiﬁcantly to the induction
of osteoclast-speciﬁc genes by regulating transcription of NFATc1,
a master regulator of osteoclastogenesis.
4. Discussion
In the present study, we have shown that ASIC1a is essential for
the extracellular acidiﬁcation-induced increase in [Ca2+]i levels in
osteoclasts. More interestingly, ASIC1a provides a pathway for
Ca2+ to enter osteoclasts in extracellular acidosis, which contrib-
utes to the acidosis-induced osteoclastogenesis. ASIC1a activation
in osteoclasts enhances their differentiation by inducing NFATc1
translocation.
It has previously been reported that mRNA encoding ASICs was
detected in human osteoclasts [16]. Our results show that ASIC1a
in particular is highly upregulated in response to acidosis, whereas
the level of other ASIC subtypes is unchanged. In acid conditions,
the transcript level of ASIC1a isoform is highly increased. Higherexpression of ASIC1a in osteoclasts may explain why acidosis does
stimulate osteoclast differentiation. This could signify a particular
sensing role for ASIC1a during acidosis in osteoclasts. The negative
impact of systemic acidosis on the skeleton has long been known
in that low pH exerts a direct stimulatory effect on multinucleated
bone-resorbing osteoclasts [21]. In the present study, we provide
direct evidence that ASIC1a is involved in pH-sensing in
osteoclasts.
Over the past several years, considerable progress has been
made towards understanding the mechanisms by which osteo-
clasts might detect and respond to changes in extracellular pH in
such an acidosis-sensitive manner [6,21]. It has been reported that
the rise of [Ca2+]i induced by extracellular acidosis contributes to
regulation of osteoclastogenesis [6]. The molecular identity of the
pathways of acid-induced Ca2+ entry are not yet known, but might
be associated with ASIC1a, as described in the present study. We
demonstrated that osteoclasts derived from rat BMMs respond to
a decrease in pH by increasing [Ca2+]i levels. This acid-induced rise
of [Ca2+]i is inhibited by the ASIC1a antagonist PcTX1, and is sup-
pressed in osteoclasts in which ASIC1a transcripts have been
3242 X. Li et al. / FEBS Letters 587 (2013) 3236–3242depleted using RNA interference. These ﬁndings support an essen-
tial role for ASIC1a in acid-induced Ca2+ signaling in osteoclasts.
It has been proposed that lowering extracellular pH induces an
increase in osteoclastogenesis (14–16, 18, 19). Moreover, some
studies have found that acidosis has a direct effect on osteoclasts,
enhancing their differentiation, adhesion, and migration [5]. Nev-
ertheless it remained unclear whether acid-induced [Ca2+]i in-
creased via ASIC1a was involved in acid-induced
osteoclastogenesis. Therefore, we measured osteoclast differentia-
tion and bone resorption. In this study, we found that ASIC1a reg-
ulates Ca2+ inﬂux and contributes to osteoclast formation and bone
resorption in osteoclasts.
Recent studies have unveiled the precise molecular mechanism
underlying osteoclast differentiation. Notably, the discovery of
NFATc1, the major regulator of osteoclast differentiation, has pro-
ven to be a breakthrough in this ﬁeld [5]. NFATc1in the nucleus
is activated by Ca2+ signaling, which explains why activation of
the Ca2+–NFATc1 pathway is crucial for osteoclast differentiation
[15]. NFATc1 induces expression of TRAP, cathepsin K, and OSCAR,
which are responsible for bone osteoclast differentiation and sur-
vival [20]. Komarova et al. [6] previously demonstrated that RANKL
and acidiﬁcation induce osteoclast function through the Ca2+/calci-
neurin/NFATc1 signaling axis in osteoclasts. Consistent with the
previous study [22], our present results conﬁrmed that, although
NFATc1 initially accumulate in the nucleus immediately after
acid-induced calcium signal, the actual transcriptional response
is integrated over substantially longer periods of time that require
maintained presence of NFATc1. Our results clearly illustrate that
ASIC1a plays a key role in induction of the expression of osteoclas-
tic genes known to be a direct transcriptional target of NFATc1 in
osteoclastogenesis. Based on these data, we propose that ASIC1a
activation in rat osteoclasts enhances their differentiation, mainly
by inducing NFATc1 translocation into the nucleus and activation
of NFATc1 transcriptional activity, which is stimulated by [Ca2+]i
elevation.
In conclusion, we found that the proton-sensitive ASIC1a was
present in rat osteoclasts. We have shown that ASIC1a-mediated
elevation of [Ca2+]i explains the effect of acidiﬁcation on osteo-
clastogenesis by regulating activation of the NFATc1. Thus, we
speculate that ASIC1a may play a role in pH sensing in osteoclasts,
which has likely been described previously as a physiological func-
tion of proton-activated channels in neurons. Our ﬁndings point to
ASIC1a as a potential therapeutic target for the treatment of hu-
man diseases caused by excessive activity of osteoclasts, such as
osteoporosis.
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